Rare diseases
Investigational molecules
Locations
Back to France613 clinical trials in Saint-Herblain, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)Efficacy and Safety of ALKS 2680 and Alixorexton in Adults with Narcolepsy Type 1
FranceA Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
FranceSafety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)
FrancePhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
FrancePhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
FranceA study to evaluate the safety and effectiveness of HLX43 in patients with advanced non-small cell lung cancer
FranceStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
FranceStudy of BNT327 with etoposide and carboplatin compared to atezolizumab with etoposide and carboplatin for patients with untreated extensive-stage small-cell lung cancer
FranceA study comparing XL092 versus everolimus in patients with previously treated advanced or metastatic neuroendocrine tumors
FranceStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
FranceStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
FranceStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, including studies for breast cancer, lung cancer, and gastric cancer. Research includes novel therapeutic approaches targeting specific cancer types.
Several trials are evaluating new antibody-drug conjugates and combination therapies for metastatic diseases.
Studies targeting various neurological conditions, with emphasis on frontotemporal dementia and multiple sclerosis. Research focuses on innovative therapeutic approaches and disease-modifying treatments.
Trials include evaluation of novel antibodies and assessment of long-term treatment efficacy.
Comprehensive research into heart failure prevention, pulmonary hypertension, and cardiac rhythm disorders. Studies focus on innovative therapeutic approaches and preventive measures.
Research includes long-term safety assessments and combination therapy evaluations.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
